SEARLE CALAN SALES PROPEL MONSANTO DRUG DIVISION TO FIRST PROFITABLE QUARTER SINCE MERGER; CALCIUM CHANNEL BLOCKER ON WAY TO $325 MIL. 1989 SALES

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".